Author:
Makita M,Azuma T,Hamaguchi H,Niiya H,Kojima K,Fujita S,Tanimoto M,Harada M,Yasukawa M
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference49 articles.
1. Klarnet JP, Kern DE, Okunu K, Holt C, Lilly F, Greenberg PD . FBL-reactive CD8 cytotoxic and CD4 helper T cells recognize distinct Friend murine leukemia virus-encoded antigens J Exp Med 1989 169: 457–467
2. Hu J, Kindsvogel W, Busby S, Bailey MC, Shi Y, Greenberg PD . An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues J Exp Med 1993 177: 1681–1690
3. Yoshimura A, Shiku H, Nakayama E . Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4−CD8− T cell receptor-αβ phenotypes generated in CD8-depleted C57BL/6 mice J Immunol 1993 150: 4900–4910
4. Giralt S, Hester J, Huh Y, Hirsch-Ginsberg C, Rondon G, Seong D, Lee M, Gajewski J, van Besien K, Khouri I, Mehra R, Przepiorka D, Korbling M, Talpaz M, Kantarjian H, Fischer H, Deisseroth A, Champlin R . CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Blood 1995 86: 4337–4343
5. Wang R-F, Wang X, Atwood AC, Topalian SL, Rosenberg SA . Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen Science 1999 284: 1351–1354
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献